Gyre Therapeutics, Inc. Interest Income (Expense), Nonoperating, Net
Gyre Therapeutics, Inc. (GYRE) reported Interest Income (Expense), Nonoperating, Net of $537.00 thousand for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-30.
Discontinued › Income Statement › Other Income
us-gaap:InterestIncomeExpenseNonoperatingNet · last filed 2023-03-30
- Gyre Therapeutics, Inc. interest income (expense), nonoperating, net for the quarter ending 2022-12-31 was $167.00K, a 4075.00% increase year-over-year.
- Gyre Therapeutics, Inc. interest income (expense), nonoperating, net for the quarter ending 2022-09-30 was $283.00K, a 3942.86% increase year-over-year.
- Gyre Therapeutics, Inc. interest income (expense), nonoperating, net for the quarter ending 2022-06-30 was $85.00K, a 672.73% increase year-over-year.
- Gyre Therapeutics, Inc. interest income (expense), nonoperating, net for the quarter ending 2022-03-31 was $2.00K, a 88.24% decline year-over-year.
- Gyre Therapeutics, Inc. interest income (expense), nonoperating, net for fiscal 2022 was $537.00K, a 1276.92% increase from fiscal 2021.
- Gyre Therapeutics, Inc. interest income (expense), nonoperating, net for fiscal 2021 was $39.00K, a 93.05% decline from fiscal 2020.
- Gyre Therapeutics, Inc. interest income (expense), nonoperating, net for fiscal 2020 was $561.00K, a 73.85% decline from fiscal 2019.
- Gyre Therapeutics, Inc. interest income (expense), nonoperating, net for fiscal 2019 was $2.15M, a 3.77% decline from fiscal 2018.
| Period end | Interest Income (Expense), Nonoperating, Net 3 month | Interest Income (Expense), Nonoperating, Net 6 month | Interest Income (Expense), Nonoperating, Net 9 month | Interest Income (Expense), Nonoperating, Net 12 month |
|---|---|---|---|---|
| 2022-12-31 | $167.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $450.00K derived: sum of 2 quarters · filed 2023-03-30 | $535.00K derived: sum of 3 quarters · filed 2023-03-30 | $537.00K 10-K · filed 2023-03-30 |
| 2022-09-30 | $283.00K 10-Q · filed 2022-11-14 | $368.00K derived: sum of 2 quarters · filed 2022-11-14 | $370.00K 10-Q · filed 2022-11-14 | $374.00K derived: sum of 4 quarters · filed 2023-03-30 |
| 2022-06-30 | $85.00K 10-Q · filed 2022-08-15 | $87.00K 10-Q · filed 2022-08-15 | $91.00K derived: sum of 3 quarters · filed 2023-03-30 | $98.00K derived: sum of 4 quarters · filed 2023-03-30 |
| 2022-03-31 | $2.00K 10-Q · filed 2022-05-09 | $6.00K derived: sum of 2 quarters · filed 2023-03-30 | $13.00K derived: sum of 3 quarters · filed 2023-03-30 | $24.00K derived: sum of 4 quarters · filed 2023-03-30 |
| 2021-12-31 | $4.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $11.00K derived: sum of 2 quarters · filed 2023-03-30 | $22.00K derived: sum of 3 quarters · filed 2023-03-30 | $39.00K 10-K · filed 2023-03-30 |
| 2021-09-30 | $7.00K 10-Q · filed 2022-11-14 | $18.00K derived: sum of 2 quarters · filed 2022-11-14 | $35.00K 10-Q · filed 2022-11-14 | $60.00K derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | $11.00K 10-Q · filed 2022-08-15 | $28.00K 10-Q · filed 2022-08-15 | $53.00K derived: sum of 3 quarters · filed 2022-08-15 | $127.00K derived: sum of 4 quarters · filed 2022-08-15 |
| 2021-03-31 | $17.00K 10-Q · filed 2022-05-09 | $42.00K derived: sum of 2 quarters · filed 2022-05-09 | $116.00K derived: sum of 3 quarters · filed 2022-05-09 | $244.00K derived: sum of 4 quarters · filed 2022-05-09 |
| 2020-12-31 | $25.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $99.00K derived: sum of 2 quarters · filed 2022-03-31 | $227.00K derived: sum of 3 quarters · filed 2022-03-31 | $561.00K 10-K · filed 2022-03-31 |
| 2020-09-30 | $74.00K 10-Q · filed 2021-11-12 | $202.00K derived: sum of 2 quarters · filed 2021-11-12 | $536.00K 10-Q · filed 2021-11-12 | $918.00K derived: sum of 4 quarters · filed 2021-11-12 |
| 2020-06-30 | $128.00K 10-Q · filed 2021-08-05 | $462.00K 10-Q · filed 2021-08-05 | $844.00K derived: sum of 3 quarters · filed 2021-08-05 | $1.33M derived: sum of 4 quarters · filed 2021-08-05 |
| 2020-03-31 | $334.00K 10-Q · filed 2021-05-06 | $716.00K derived: sum of 2 quarters · filed 2021-05-06 | $1.21M derived: sum of 3 quarters · filed 2021-05-06 | $1.81M derived: sum of 4 quarters · filed 2021-05-06 |
| 2019-12-31 | $382.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-04 | $871.00K derived: sum of 2 quarters · filed 2021-03-04 | $1.47M derived: sum of 3 quarters · filed 2021-03-04 | $2.15M 10-K · filed 2021-03-04 |
| 2019-09-30 | $489.00K 10-Q · filed 2020-11-05 | $1.09M derived: sum of 2 quarters · filed 2020-11-05 | $1.76M 10-Q · filed 2020-11-05 | $2.41M derived: sum of 4 quarters · filed 2020-11-05 |
| 2019-06-30 | $601.00K 10-Q · filed 2020-08-06 | $1.26M 10-Q · filed 2020-08-06 | $1.92M derived: sum of 3 quarters · filed 2020-08-06 | $2.57M derived: sum of 4 quarters · filed 2020-08-06 |
| 2019-03-31 | $631.00K 10-Q · filed 2020-05-11 | $1.32M derived: sum of 2 quarters · filed 2020-05-11 | $1.97M derived: sum of 3 quarters · filed 2020-05-11 | $2.58M derived: sum of 4 quarters · filed 2020-05-11 |
| 2018-12-31 | $690.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-20 | $1.34M derived: sum of 2 quarters · filed 2020-02-20 | $1.94M derived: sum of 3 quarters · filed 2020-02-20 | $2.23M 10-K · filed 2020-02-20 |
| 2018-09-30 | $652.00K 10-Q · filed 2019-11-07 | $1.25M derived: sum of 2 quarters · filed 2019-11-07 | $1.54M 10-Q · filed 2019-11-07 | $1.57M derived: sum of 4 quarters · filed 2019-11-07 |
| 2018-06-30 | $602.00K 10-Q · filed 2019-08-01 | $887.00K 10-Q · filed 2019-08-01 | $917.00K derived: sum of 3 quarters · filed 2019-08-01 | $1.00M derived: sum of 4 quarters · filed 2019-08-01 |
| 2018-03-31 | $285.00K 10-Q · filed 2019-05-02 | $315.00K derived: sum of 2 quarters · filed 2019-05-02 | $400.00K derived: sum of 3 quarters · filed 2019-05-02 | $453.00K derived: sum of 4 quarters · filed 2019-05-02 |
| 2017-12-31 | $30.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-08 | $115.00K derived: sum of 2 quarters · filed 2019-03-08 | $168.00K derived: sum of 3 quarters · filed 2019-03-08 | $215.00K 10-K · filed 2019-03-08 |
| 2017-09-30 | $85.00K 10-Q · filed 2018-11-01 | $138.00K derived: sum of 2 quarters · filed 2018-11-01 | $185.00K 10-Q · filed 2018-11-01 | |
| 2017-06-30 | $53.00K 10-Q · filed 2018-08-02 | $70.00K 10-Q · filed 2018-08-02 | ||
| 2017-03-31 | $17.00K 10-Q · filed 2018-05-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |